Introduction dom integration of the inserted genes, and thus each Tumor cells transduced with a retroviral vector carrying
HSVtk-transduced tumor cell (TK cell) within the bulk the herpes simplex thymidine kinase gene (HSVtk) are tumor population will have a unique site of vector intekilled upon exposure to the antiherpes drug ganciclovir gration. The consequence of random integration is that (GCV) (9-(1,3-dihydroxy-2-propoxymethyl) guanine). 1, 2 the treated tumor deposit will consist of a mixture of cells Herpes simplex thymidine kinase (TK) has significant having widely variable levels of HSVtk gene expression affinity for GCV while normal cellular thymidine kinase with some cells probably not expressing the inserted does not, and thus the drug is preferentially phosphorylHSVtk gene at all. ated in cells expressing the viral gene. GCV-MP is then These limitations might be overcome if an associated further phosphorylated by normal cellular kinases to the mechanism to amplify the antitumor effect of GCV treatdiphosphate and toxic triphosphate forms. 3, 4 Phosphorylment were also present. We observed that GCV treatment ated GCV acts as a DNA polymerase inhibitor and a caused complete regression of not only those tumors in chain terminator, leading to the death of prodrug-treated which all cells were TK positive, but also of some tumors TK expressing cells. 5, 6 We and others have worked with established from mixtures containing as many as 90% this HSVtk gene system to explore its potential use in canwild-type tumor cells (WT cells) mixed with only 10% TK cer treatment, exploiting the restriction that retroviral cells. 7 This important antitumor phenomenon was vectors only integrate into dividing cells as a means of termed the 'bystander effect', and this report describes targeting gene delivery to a tumor located in an organ studies exploring the mechanism by which tumor cells where the normal resident cells are not proliferating (eg not expressing the HSVtk gene are killed as bystanders brain).
findings, cell mixtures were injected subcutaneously in injected with xenogeneic mixtures of the bystander-sensitive murine tumor MC38-WT with bystander-sensitive normal mice and twice daily i.p. injections of the antiherpes drug GCV were given between days 4 and 10.
human tumor A375-TK, or bystander-resistant human tumors 888-TK or K562-TK. Half of the mice in each Figure 1a shows the results of several experiments in C57BL/6 mice involving three different murine tumor group were then treated with GCV and the growth of the tumors evaluated. As seen in Figure 3b , mixed tumors cell lines, MC38, MCA-102 and MCA-205. In each case the control animals receiving only WT cells developed prepared from bystander-sensitive cell combinations (MC38 with MC38-TK or A375-TK) showed substantial progressively growing tumors that did not respond to GCV treatment (tumor free/total: 0/30 (0%) ). By congrowth inhibition indicating that the bystander-sensitive phenotype was also present in vivo. By contrast, growth trast, most of the animals (52 of 56 (93%) ) receiving TKexpressing tumor cells and subsequently treated with of bystander-resistant cell combinations (MC38 with 888-TK or K562-TK) were unaffected by GCV treatment and GCV failed to grow tumors during the 6-week observation period. The bystander effect is clearly illustrated maintained their bystander-resistant phenotype in vivo. in those animals bearing tumors established from cell mixtures consisting of equal proportions of WT and TK Phosphorylation of GCV in TK+ cells GCV must be phosphorylated to kill mammalian cells. tumor cells (35 of 36 (97%) ) and even more convincingly with mixtures of 90% WT and only 10% TK tumor cells Therefore to further explore bystander killing we measured levels of phosphorylated metabolites in TK+ cells, (22 of 40 (55%) ).
To clarify the mechanisms underlying this 'bystander WT cells and in mixtures of TK+ and WT cells. WT-and TK-expressing tumors were treated with 3 H-GCV and 24 effect' we developed an in vitro assay of this phenomenon. Incorporation of 3 H-thymidine into DNA of GCV h later they were lysed and analyzed by HPLC for the generation of phosphorylated metabolites of GCV. 13 As treated proliferating tumor cell mixtures seemed to mimic in vitro the 'bystander effect' that we had observed expected lysates from WT tumor cells showed uptake of GCV but very little conversion of the parent drug to a for tumor growth in vivo. Figure 1b shows the in vitro results of this assay on the same three tumor populations phosphorylated derivative (Table 1A) . By contrast GCVsensitive TK transduced tumor cells, either bystanderthat showed 'bystander sensitivity' in vivo. In each case, mixtures of WT-and TK-expressing cells showed subsensitive or resistant, contained large amounts of phosphorylated GCV, particularly of the active metabolite stantially more inhibition of 3 H-thymidine incorporation than would be expected simply from inhibition of the GCV-TP. portion of tumor cells in the mixture that was expressing the HSVtk gene.
Detection of phosphorylated GCV in bystander-sensitive WT cells cocultured with TK+ cells Figure 2 illustrates the responses of two cell lines, MC38, a murine adenocarcinoma and A375, a human As demonstrated above WT tumor cells themselves cannot efficiently phosphorylate GCV, but are killed by GCV melanoma, that were 'sensitive' to bystander killing in these in vitro mixtures of GCV-treated WT-and TKwhen mixed with TK+ cells. This could be explained by:
(1) transport of TK enzyme or gene from TK+ to WT cells; expressing tumors. Not all cell lines were sensitive to bystander killing. Another human melanoma cell line, (2) transport of phosphorylated GCV from TK+ to WT cells; or (3) uptake of phosphorylated GCV released into 888, and the human leukemia line K562 were relatively resistant to bystander killing in the same assay, although the extracellular space by TK+ cells. To test these hypotheses we measured GCV metabolites in WT cells which each of these cell lines, when consisting of 100% HSVtk gene expressing cells, was readily killed with GCV treathad been cocultured with TK+ cells. Separation of WT and TK+ cells after coculture was facilitated by using ment (data not shown). H-GCV and formation of 888-TK and K562-TK with the 'bystander-sensitive' MC38 line did not result in bystander killing of the MC38-WT phosphorylated 3 H-GCV metabolites was measured in each population. As seen in Table 1B , very little cells. The converse cell combinations in which bystandersensitive MC38-TK cells were used to mediate bystander phosphorylated 3 H-GCV was found in the WT cells cocultured with TK+ cells but separated before GCV killing showed effective inhibition of the sensitive lines MC38-WT and K562-WT (data not shown). These experitreatment.
To determine if toxic GCV metabolites were passed ments clearly indicate that bystander killing can occur between xenogeneic cell mixtures and that the phenotype from TK+ cells to WT cells, bystander-sensitive murine tumor MC38-WT cells were cocultured with bystanderof 'bystander resistance' seen in autologous TK and WT mixtures is similarly observed in xenogeneic cell combisensitive human tumor A375-TK cells in the presence of 3 H-GCV. The TK+ and WT populations were then separnations.
To confirm these observations in vivo nude mice were ated. High levels of phosphorylated 3 H-GCV metabolites 
Discussion
These studies have demonstrated that the 'bystander effect' observed in vivo could be reproduced in an in vitro assay using DNA synthesis as a measure of cellular proliferation. This in vitro assay then permitted dissection of the mechanisms involved in bystander killing and led to the demonstration that the bystander effect appears to correlate with the cell to cell transfer of phosphorylated GCV from the TK-expressing cells to adjacent WT cells. Several important corollary observations were also made. Tumor cells that were resistant to bystander killing were identified. The resistant phenotype appeared to be dominant since these 'resistant' cells were not only resistant to bystander killing but also were inefficient in donating the 'bystander effect' in mixture experiments with 'sensitive' cells. Xenogeneic cell mixtures could show the 'bystander effect' so that its mechanism is not restricted to homologous cell types nor is it even species restricted. observed. Our in vitro assay demonstrated that DNA synthesis ceased in TK-expressing cells within 6 h of exposure to GCV, while the treated cells remained viable as measured by trypan blue exclusion for 3-5 additional days (data not shown). In the cell coculture-separation were found in both TK+ and WT populations, compatible experiments, substantial GCV-xP transfer from the TK to with cell to cell transfer of one or more of the phosphoryl-WT cells was detected well before the time that GCVated metabolites of GCV from TK+ to WT cells during the treated TK cells became unable to exclude trypan blue 24 h coculture period (Table 1C) . Importantly, identical and before apoptotic vesicles from dying cells were cocultures carried between the relatively bystanderpresent in the cultures. Others have also recently shown resistant combinations of MC38-WT with either 888-TK that bystander killing occurs by 10 h, well before death or K562-TK showed relatively little phosphorylated 3 Hand fragmentation of TK+ cells. 15 In addition, the TK-GCV in WT cells. The presence of activated GCV-xP expressing tumor cells that were resistant to the metabolites in WT cells could result from either interbystander effect (888-TK and K562-TK) were themselves cellular transport of these metabolites or uptake by WT directly killed by GCV treatment but still could not cells of extracellular GCV metabolites released by dying 'donate' the bystander effect to otherwise 'bystander-TK+ cells. To test these possibilities bystander sensitive sensitive' WT cells. Freeman et al also reported detection WT cells were incubated in lysates of TK+ cells preby RT-PCR of the production of cytokines such as ILviously incubated in GCV. Following a 24 h incubation 1␣ and IL-6 within resected GCV-treated TK tumors and of 1 × 10 6 TK+ cells/ml in 5 m 3 H-GCV the TK+ lysates concluded that this cytokine release enhances the contained GCV-MP 19.2 pmol/ml, GCV-DP 0.41 bystander effect in vivo by immunostimulation. 16 Such pmol/ml, and GCV-TP Ͻ0.02 pmol/ml. Only TK+ cells immunostimulation cannot explain the 'bystander effect' can efficiently produce GCV-MP from GCV, while norinvestigated in our present report since these effects were mal kinases in wild-type cells can further phosphorylate observed in vitro in cultures containing only tumor cells GCV-MP to GCV-DP and GCV-TP. 3, 4 Therefore, if WT and no cellular components of the immune system. cells obtained GCV-MP from the lysate, significant
Our data demonstrate unequivocally the presence of amounts of GCV-MP, -DP and -TP should be detectable.
the three phosphorylated metabolites of GCV in cells sub-WT bystander-sensitive tumor cells were incubated in ject to the bystander effect, predominantly the pharmacothis lysate for 24 h at 1 × 10 6 cells/ml and then GCV logically active metabolite, GCV-TP. Our results support metabolites were measured. WT cells contained Ͻ0. 02 an alternative mechanism, proposed also by Bi et al 17 in pmol/ml GCV-MP, Ͻ0.02 pmol/ml GCV-DP and 0.07 their studies demonstrating by means of 3 H-GCV and pmol/ml GCV-TP. Taken together these data are compatautoradiography the apparent cell to cell transfer of ible with the conclusion that the bystander effect in this radioactivity that correlated with bystander killing in TK/GCV system involves cell to cell transfer of phostheir in vitro system. It has been recognized for nearly 30 phorylated GCV, but does not involve either cell to cell years that a mechanism for cell to cell transfer of small transfer of the HSVtk gene or TK enzyme, nor the uptake molecules exists which results in metabolic cooperation of phosphorylated GCV from the medium surrounding between those cells. Subak-Sharpe et al 18, 19 demonstrated that HGPRT-deficient cells could not incorporate the WT cell. H-GCV (5 m, 2 Ci/ml) for 24 h. Ganciclovir monophosphate (GCV-MP), diphosphate (GCV-DP), and triphosphate (GCV-TP) concentrations were quantified as described. 13 B. Two million murine MC38 WT cells were cocultured with two million human A375 TK or 888 TK cells in 4 ml medium without the addition of GCV. After 24 h of incubation, the HSVtk gene expressing human cells was separated from the WT murine cells by an immunomagnetic bead system employing murine monoclonal antibodies directed at cell surface determinants unique to the human cell partner. The purified murine MC38 WT cells were then cultured with 
(MC38 TK + MC38 WT (˿), A375 TK + MC38 WT (ȣ), 888TK + MC38 WT (̆), K562 TK + MC38 WT (×)). Tumor incidence in the GCV-treated (MC38TK + MC38WT) group was significantly less than that in the no-treatment group at weeks 1-6, and in the GCV-treated (A375TK

Materials and methods
and with ionic coupling of the cells. 20 The mono-, di-and triphosphates of GCV are well within the molecular Cell lines weight range of molecules which are permitted passage MC 38 is a murine colon adenocarcinoma, and MCA 205 through gap junctions. Our xenogeneic coculture cell sepand 102 are murine fibrosarcomas (gifts of SA Rosenberg, aration data clearly show that cell to cell transfer of 3 H-NCI) 29 derived from C57BL/6 mice. A375 and 888 are GCV-xP does occur. These findings are compatible with human melanoma cell lines 30, 31 (888 is a gift of SA recent observations that bystander killing cannot be conRosenberg). K562 is a line derived from a human chronic ferred by cell lysates but requires cell to cell contact [21] [22] [23] myelogenous leukemia. A375 and K562 were obtained through gap junctions. [24] [25] [26] [27] [28] The requirement for contact is from American Type Culture Collection (Rockville, MD, consistent with the original observation by Moolten 1 that USA). MC38, 205, 102 and K562 were grown in RPMI WT cells could be killed by TK+ cells when cocultured 1640 while A375 and 888 were grown in DMEM. Media at high concentrations, but not at low concentrations.
were supplemented with 10% heat inactivated fetal calf The demonstration that some tumor cells are relatively serum, 50 IU/ml penicillin, 50 g/ml streptomycin, 250 bystander-sensitive while others are more bystanderng/ml amphotericin-B and 2 mm l-glutamine. resistant has significant implications for the effectiveness of this HSVtk gene transfer strategy in cancer therapy. Clearly, tumors consisting of cells of a bystander-resistant Gene transfer procedures Murine and human tumor cell lines were transduced by phenotype would not be attractive candidates for local HSVtk gene delivery strategies which have transfer a single overnight exposure to a supernatant containing the retroviral vector STK 1 which had been produced with efficiencies of less than 100%, since the therapeutic amplification provided by the bystander effect would not be the PA317 amphotropic packaging cell line. STK contains the herpes simplex thymidine kinase gene under the tranavailable. A major challenge will be the development of procedures to test individual clinical tumor specimens in scriptional control of an internal simian virus 40 promoter and a neo gene as a selectable marker. The transorder to predict their sensitivity to this process. In the duced tumor cells were selected for successful gene sinization and washed three times in HBSS. Adult C57BL/6 mice were injected subcutaneously with a total insertion and expression in the neomycin analogue G418 at 1.0 mg/ml for 7 days. of 10 5 tumor cells in 0.1 ml HBSS at the ratios of WT to TK cells specified in the text. GCV (150 mg/kg) was given 3 H-thymidine incorporation assay intraperitoneally twice daily from day 4 to day 10 after The inhibitory effect of GCV (Syntex, Palo Alto, CA, tumor injection. Tumor growth was monitored for at USA) was measured by a 3 H-thymidine incorporation least 6 weeks after tumor injection. All animal experiassay 32 in which mixtures of 10 4 tumor cells consisting of ments were carried out in accordance with the guidelines different proportions of WT and TK cells were cultured established by the National Cancer Institute Animal Care in 96-well flat bottom microtiter plates overnight and to and Use Committee. which GCV was added at final concentrations of 0, 0.5, HPLC 5 and 50 m. After 18 h of GCV exposure wells were TK or WT tumor cells as indicated were cultured at pulsed with 0.5 Ci per well 3 H-thymidine and harvested 10 6 /ml with 3 H-GCV (5 m, 2 Ci/ml) for 24 h ( 3 H-GCV; 6 h later. The effect of GCV on tumor cell proliferation is Moravek Biochemicals, Brea, CA, USA). The cell pellets expressed as a percentage of the thymidine incorporation were extracted with 60% methanol and heated for 2 min found in the identical cultures not treated with GCV.
at 95°C. After centrifugation, the supernatant was evaporated under vacuum and redissolved in water. The Animal experiments Tumor cell injections were carried out using freshly prereconstituted samples were analyzed by HPLC on a Partisphere 5-SAX column (Whatman, Clifton, NJ, USA). pared tumor cells removed from culture plates by tryp-
